Selvita S.A. (SLV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Selvita S.A. (SLV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Selvita S.A. (SLV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Selvita S.A. (SLV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
29 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Selvita S.A. (Selvita) is a drug discovery company that undertakes the research and development in the area of oncology. The companys research and development pipeline product portfolio includes products such as SEL24, SEL303, SEL120, SEL201, SEL212, kinase discovery platform and cancer metabolism platform. Its products find application in the therapeutic areas of colorectal cancer, leukemia, solid tumour, oncology, Alzheimer's disease and cognitive disorders, among others.

Selvita S.A. (SLV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

  
Source:
Document ID
GDPH248860D
Country
Industry
Ticker
SLV=PL
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Selvita S.A., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Selvita S.A., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Selvita S.A., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Selvita S.A., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Selvita S.A., Medical Devices Deals, 2010 to YTD 201691
Selvita S.A., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Selvita S.A., Pharmaceuticals &Healthcare, Deal Details1115
  Partnerships111
    Selvita Enters into Agreement with University of California, San Francisco111
    Selvita Enters into Agreement with Merck121
    Selvita Enters into Development and Commercialization Agreement with Merck131
    Felicitex Therapeutics Enters into Co-Development Agreement with Selvita141
    Merck Serono Enters Into Co-Development Agreement With Selvita For Cancer Drugs151
    H3 Biomedicine Extends Agreement with Selvita161
    Selvita Enters Into Co-Development Agreement With Orion172
  Licensing Agreements191
    Merck Enters into Licensing Agreement with Selvita191
  Equity Offering201
    Selvita Raises USD0.1 Million in Private Placement of Shares202
    Selvita Raises USD8 Million in IPO222
    Selvita Completes Private Placement Of US$5.5 Million241
  Acquisition251
    Selvita Acquires Remaining 36% Stake In BioCentrum251
Selvita S.A. - Key Competitors261
Key Employees271
Locations And Subsidiaries281
  Head Office281
  Other Locations &Subsidiaries281
Appendix291
  Methodology291
  About GlobalData291
  Contact Us291
  Disclaimer291

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Selvita S.A. (SLV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Selvita-S-A-SLV-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7607>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Selvita S.A. (SLV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Selvita-S-A-SLV-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7607>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research